These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 21659946

  • 41. Thrombolytic treatment of portal thrombosis.
    Malkowski P, Pawlak J, Michalowicz B, Szczerban J, Wroblewski T, Leowska E, Krawczyk M.
    Hepatogastroenterology; 2003; 50(54):2098-100. PubMed ID: 14696472
    [Abstract] [Full Text] [Related]

  • 42. [Experiences with surgical therapy of Budd-Chiari syndrome].
    Rückert JC, Wolff H, Ridwelski K, Rudolph B, Staffa G, Romaniuk P.
    Zentralbl Chir; 1992; 117(5):282-93. PubMed ID: 1642051
    [Abstract] [Full Text] [Related]

  • 43. Acute Budd-Chiari syndrome with liver failure: the experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt.
    Kavanagh PM, Roberts J, Gibney R, Malone D, Hegarty J, McCormick PA.
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1135-9. PubMed ID: 15377290
    [Abstract] [Full Text] [Related]

  • 44. Surgical treatment of Budd-Chiari syndrome.
    Klein AS, Molmenti EP.
    Liver Transpl; 2003 Sep; 9(9):891-6. PubMed ID: 12942449
    [Abstract] [Full Text] [Related]

  • 45. [Treatment of advanced Budd-Chiari syndrome by liver transplantation].
    Knoop M, Lang M, Neumann U, Bechstein WO, Neuhaus P.
    Chirurg; 1998 Dec; 69(12):1362-8. PubMed ID: 10023564
    [Abstract] [Full Text] [Related]

  • 46. Prevention of thrombosis and embolism in children and adolescents with mechanical valve prostheses: warfarin versus antiplatelet agents.
    Khitin LM, Sade RM, Bradley SM, Crawford FA, Widener CE, Stroud MR.
    J Heart Valve Dis; 2006 May; 15(3):394-9; discussion 399. PubMed ID: 16784079
    [Abstract] [Full Text] [Related]

  • 47. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation.
    Hemming AW, Langer B, Greig P, Taylor BR, Adams R, Heathcote EJ.
    Am J Surg; 1996 Jan; 171(1):176-80; discussion 180-1. PubMed ID: 8554136
    [Abstract] [Full Text] [Related]

  • 48. Etiology based prevalence of Budd-Chiari syndrome in eastern India.
    De BK, De KK, Sen S, Biswas PK, Das TK, Das S, Hazra B.
    J Assoc Physicians India; 2000 Aug; 48(8):800-3. PubMed ID: 11273472
    [Abstract] [Full Text] [Related]

  • 49. Liver transplant in Budd-Chiari syndrome: a single-center experience in Saudi Arabia.
    Saleh Y, Eldeen FZ, Kamel Y, Kabbani M, Al Sebayel M, Broering D.
    Exp Clin Transplant; 2014 Feb; 12(1):52-4. PubMed ID: 24471724
    [Abstract] [Full Text] [Related]

  • 50. Surgical treatment of Budd-Chiari syndrome induced by Behcet's disease.
    Kuniyoshi Y, Koja K, Miyagi K, Uezu T, Yamashiro S, Arakaki K, Mabuni K, Senaha S.
    Ann Thorac Cardiovasc Surg; 2002 Dec; 8(6):374-80. PubMed ID: 12517299
    [Abstract] [Full Text] [Related]

  • 51. Radical surgery for Budd-Chiari syndrome through exposure of the entire inferior vena cava of the hepatic segment.
    Zhang XM, Li QL.
    Chin Med J (Engl); 2007 Apr 20; 120(8):626-9. PubMed ID: 17517174
    [Abstract] [Full Text] [Related]

  • 52. Twenty years' follow-up of portal vein conduits in liver transplantation.
    Nikitin D, Jennings LW, Khan T, Vasani S, Ruiz R, Sanchez EQ, Chinnakotla S, Levy MF, Goldstein RM, Klintmalm GB.
    Liver Transpl; 2009 Apr 20; 15(4):400-6. PubMed ID: 19326411
    [Abstract] [Full Text] [Related]

  • 53. Budd-Chiari syndrome.
    Plessier A, Valla DC.
    Semin Liver Dis; 2008 Aug 20; 28(3):259-69. PubMed ID: 18814079
    [Abstract] [Full Text] [Related]

  • 54. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome.
    Smalberg JH, Darwish Murad S, Braakman E, Valk PJ, Janssen HL, Leebeek FW.
    Haematologica; 2006 Dec 20; 91(12):1712-3. PubMed ID: 17145613
    [Abstract] [Full Text] [Related]

  • 55. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP, Bounameaux H.
    Thromb Haemost; 2002 Apr 20; 87(4):586-92. PubMed ID: 12008939
    [Abstract] [Full Text] [Related]

  • 56. Budd-Chiari syndrome: a single-center experience.
    Pavri TM, Herbst A, Reddy R, Forde KA.
    World J Gastroenterol; 2014 Nov 21; 20(43):16236-44. PubMed ID: 25473178
    [Abstract] [Full Text] [Related]

  • 57. Do postliver transplant patients need thromboprophylactic anticoagulation?
    Mukerji AN, Karachristos A, Maloo M, Johnson D, Jain A.
    Clin Appl Thromb Hemost; 2014 Oct 21; 20(7):673-7. PubMed ID: 24917126
    [Abstract] [Full Text] [Related]

  • 58. Long-term follow-up study and comparison of meso-atrial shunts and meso-cavo-atrial shunts for treatment of combined Budd-Chiari syndrome.
    Chen H, Zhang F, Ye Y, Cheng Y, Chen Y.
    J Surg Res; 2011 Jun 01; 168(1):162-6. PubMed ID: 20036391
    [Abstract] [Full Text] [Related]

  • 59. Early aspirin therapy may reduce hepatic artery thrombosis in liver transplantation.
    Shay R, Taber D, Pilch N, Meadows H, Tischer S, McGillicuddy J, Bratton C, Baliga P, Chavin K.
    Transplant Proc; 2013 Jun 01; 45(1):330-4. PubMed ID: 23267805
    [Abstract] [Full Text] [Related]

  • 60. Good long-term outcome of Budd-Chiari syndrome with a step-wise management.
    Seijo S, Plessier A, Hoekstra J, Dell'era A, Mandair D, Rifai K, Trebicka J, Morard I, Lasser L, Abraldes JG, Darwish Murad S, Heller J, Hadengue A, Primignani M, Elias E, Janssen HL, Valla DC, Garcia-Pagan JC, European Network for Vascular Disorders of the Liver.
    Hepatology; 2013 May 01; 57(5):1962-8. PubMed ID: 23389867
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.